🔥🐔 BizChicken 🐔🔥
Companies Similar to MeiraGTx Holdings plc
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Gain Therapeutics, Inc.
Site-Directed Enzyme Enhancement Therapy platform
Gain Therapeutics, Inc. is a biotechnology company developing therapies for diseases caused by protein misfolding, focusing on rare genetic diseases and neurological disorders. It utilizes its proprietary technology to discover and develop molecules targeting misfolded proteins.
Symbol: GANX
Recent Price: $2.18
Industry: Biotechnology
CEO: Mr. Gene Mack M.B.A.
Sector: Healthcare
Employees: 29
Address: 4800 Montgomery Lane, Bethesda, MD 20814
Phone: 301 500 1556
Last updated: 2024-12-31
Lyra Therapeutics, Inc.
XTreo technology platform
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company developing integrated drug and delivery solutions for ear, nose, and throat diseases using its XTreo technology platform. It focuses on product candidates like LYR-210 and LYR-220 for chronic rhinosinusitis.
Symbol: LYRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Dr. Maria Palasis Ph.D.
Sector: Healthcare
Employees: 88
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617 393 4600
Leadership
- Harlan W. Waksal, M.D., Executive Chairman
- Maria Palasis, Ph.D., President and Chief Executive Officer
- Jason Cavalier, Chief Financial Officer
- Robert Kern, M.D., Chief Clinical Advisor
- Ronan O’Brien, Chief Legal Officer
- Vineeta Belanger, Ph.D., Senior Vice President of Clinical Affairs
- Gloria Cosgrove, Senior Vice President of Quality
- Allison Nance, Senior Vice President of Regulatory Affairs
- Michael Altman, CFA, Managing Director, Perceptive Advisors
- Ann Merrifield, Life Sciences Advisor and Board Director
- Konstantin Poukalov, Managing Director, Perceptive Advisors
- Bradford Smith, Board Director
- Nancy L. Snyderman, M.D., Board Director
- Jim Tobin, Lead Independent Director
- Robert Langer, D.Sc., David H. Koch Institute Professor, Massachusetts Institute of Technology
- George Whitesides, Ph.D., Woodford L. and Ann A. Flowers University Professor, Harvard University
Last updated: 2024-12-31
Genprex, Inc.
REQORSA (GPX-001)
Genprex, Inc. is a clinical-stage gene therapy company developing therapies for cancer and diabetes, with a lead product candidate REQORSA for lung cancer treatment.
About | Management | Leadership | Directors | About | About | About | About | Contact | Safety | About | About | News | Careers | About | About | About
Symbol: GNPX
Recent Price: $0.85
Industry: Biotechnology
CEO: Mr. Ryan M. Confer M.S.
Sector: Healthcare
Employees: 21
Address: 3300 Bee Cave Road, Austin, TX 78746
Phone: 877 774 4679
Leadership
- Amy Patel, Quality Assurance Manager
- Celina Laney, Senior Administrative Services Manager
- Edith Padilla, Clinical Research Associate II
- Gina Johnson, Quality Control Manager, Stability & Product Lifecycle Management
- Greg Jancarik, MBA, CMA, CPA, Corporate Controller
- Jackie Opiola, Senior Clinical Project Manager
- John Ayres, Associate Vice President & Associate General Counsel
- Kalyn Dabbs, Senior Manager of Communications and Marketing
- Kate Combs, Vice President of Clinical Operations
- Laura Tirado, Senior Manager, CMC Project Management
- Olivia Stancil, Senior Clinical Trial Assistant
- Pier-Anne Lachance, Director of Quality Control & Product Development
- Sarah Nguyen, Senior Manager of Quality Assurance Operations
- Jose A. Moreno Toscano, Board Chairman
- Ryan M. Confer, MS, President, Chief Executive Officer, Chief Financial Officer
- Brent Longnecker, Board Director
- William Wilson, Jr., Board Director
- James E. Rothman, PhD, Strategic Advisor to the Board of Directors
Last updated: 2024-12-31
Taysha Gene Therapies, Inc.
TSHA-120, TSHA-102, TSHA-121, TSHA-118, TSHA-105, TSHA-101
Taysha Gene Therapies, Inc. focuses on developing adeno-associated virus-based gene therapies for treating monogenic diseases of the central nervous system, with a pipeline including treatments for conditions such as giant axonal neuropathy, Rett syndrome, and GM2 gangliosidosis.
Symbol: TSHA
Recent Price: $1.73
Industry: Biotechnology
CEO: Mr. Sean P. Nolan
Sector: Healthcare
Employees: 52
Address: 3000 Pegasus Park Drive, Dallas, TX 75247
Phone: 214 612 0000
Last updated: 2024-12-31
GeneDx Holdings Corp.
Centrellis health intelligence platform
Gene Dx Holdings Corp. is a patient-centered health intelligence company focused on transforming healthcare by leveraging AI and machine learning on clinical and genomic data to improve individual health outcomes.
Symbol: WGS
Recent Price: $76.58
Industry: Medical - Healthcare Information Services
CEO: Ms. Katherine A. Stueland
Sector: Healthcare
Employees: 1000
Address: North Tower, Stamford, CT 06902
Phone: 800 298 6470
Last updated: 2024-12-31
Beam Therapeutics Inc.
precision genetic medicines
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States, with a focus on conditions such as sickle cell disease, beta thalassemia, and Glycogen Storage Disease Type Ia.
About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About | About | Careers | About | Jobs | Careers
Symbol: BEAM
Recent Price: $25.28
Industry: Biotechnology
CEO: Mr. John M. Evans M.B.A.
Sector: Healthcare
Employees: 472
Address: 238 Main Street, Cambridge, MA 02142
Phone: 857 327 8775
Last updated: 2024-12-31
EyeGate Pharmaceuticals, Inc.
EGP-437
Eye Gate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye.
About | Vision/Values | Directors | About | Management | Contact
Symbol: EYEG
Recent Price: $35.04
Industry: Biotechnology
CEO: Mr. Stephen From
Sector: Healthcare
Employees: 14
Address: 271 Waverley Oaks Rd Ste 108, Waltham, MASSACHUSETTS 02452
Phone: 17817889043
Leadership
- Paul Chaney, Chairman of the Board
- Morton F. Goldberg, MD, Director
- Praveen Tyle, PhD, Director
- Thomas Balland, Director
- Thomas E. Hancock, Director
- Bernard Malfroy-Camine, PhD, Director
- Mounia Chaoui, PhD, Director
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Generation Bio Co.
genetic medicines
Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.
Symbol: GBIO
Recent Price: $1.06
Industry: Biotechnology
CEO: Dr. Cameron Geoffrey McDonough M.D.
Sector: Healthcare
Employees: 174
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 655 7500
Last updated: 2024-12-31
Lexeo Therapeutics, Inc. Common Stock
LX2006, LX2020, LX2021, LX2022, LX1001, LX1020, LX1021, LX1004
Lexeo Therapeutics is a clinical-stage genetic medicine company developing innovative gene therapy candidates targeting hereditary and acquired diseases, including cardiomyopathies and neurological conditions.
Symbol: LXEO
Recent Price: $6.54
Industry: Biotechnology
CEO: Mr. R. Nolan Townsend
Sector: Healthcare
Employees: 69
Address: 345 Park Avenue South, New York, null 10010
Phone: 212-547-9879
Last updated: 2024-12-31
MEI Pharma, Inc.
Zandelisib
MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.
About | About | About | Contact | Contact | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Site Map | Careers | Careers | Careers | About | About | About | About | About | Jobs | About
Symbol: MEIP
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Justin J. File
Sector: Healthcare
Employees: 28
Address: 11455 El Camino Real, San Diego, CA 92130
Phone: 858 369 7100
Last updated: 2024-12-31
MIRA Pharmaceuticals, Inc.
MIRA1a
MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company focusing on the development and commercialization of a new molecular synthetic THC analog for treating anxiety and cognitive decline associated with early-stage dementia.
Symbol: MIRA
Recent Price: $1.14
Industry: Drug Manufacturers - General
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 2
Address: 855 North Wolfe Street, Baltimore, MD 21205
Phone: 737-289-0835
Leadership
- Erez Aminov, Chairman of the Board and Chief Executive Officer
- Itzchak Angel, PhD, Chief Scientific Advisor
- Michelle Yanez, MBA, Chief Financial Officer, Secretary, and Treasurer
- Matthew Del Giudice, MD, Director
- Michael Jerman, Director
- Ned Macpherson, Director
- Denil N. Shekhat, MD, Director
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
Ultragenyx Pharmaceutical Inc.
Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.
Leadership | About | About | About
Symbol: RARE
Recent Price: $42.27
Industry: Biotechnology
CEO: Dr. Emil D. Kakkis M.D., Ph.D.
Sector: Healthcare
Employees: 1276
Address: 60 Leveroni Court, Novato, CA 94949
Phone: 415 483 8800
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
TransCode Therapeutics, Inc.
TTX-MC138
Trans Code Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs and diagnostics for treating metastatic disease. Their lead product, TTX-MC138, is aimed at metastatic cancer treatment, along with a range of other therapeutic platforms targeting cancer through innovative RNA- and CRISPR-based technologies.
Symbol: RNAZ
Recent Price: $3.76
Industry: Biotechnology
CEO: Mr. Thomas A. Fitzgerald M.B.A.
Sector: Healthcare
Employees: 10
Address: 6 Liberty Square, Boston, MA 02109
Phone: 857-837-3099
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
MeiraGTx Holdings plc
Gene Therapy Treatments
Meira GTx Holdings plc is a clinical stage gene therapy company developing treatments for serious diseases, including ocular diseases, xerostomia, and neurodegenerative conditions. They are in various stages of clinical development for several gene therapy programs and have a research collaboration with Janssen Pharmaceuticals.
About | Leadership | About | Contact | About | About | About | News | About | About | About | Directors
Symbol: MGTX
Recent Price: $5.89
Industry: Biotechnology
CEO: Dr. Alexandria Forbes Ph.D.
Sector: Healthcare
Employees: 387
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 860 7985
Leadership
- Alexandria Forbes, Ph.D., Board Member, President and Chief Executive Officer
- Richard Giroux, Chief Operating Officer and Chief Financial Officer
- Stuart Naylor, Ph.D., Chief Development Officer
- Robert K. Zeldin, M.D., Chief Medical Officer
- Robert Wollin, JD, General Counsel and Secretary
- Alastair Leighton, Ph.D, SVP, Manufacturing and Supply Chain
- Christine Sheehy, SVP, Global Integration
- Tim Randall, SVP, Risk and Internal Controls
- Michel Michaelides, M.D., Head of Clinical Ophthalmology
- Tassos Georgiadis, Ph.D., Vice President, Preclinical Development
- Keith R. Harris, Ph.D., Chairman of the Board
- Ellen Hukkelhoven, Ph.D., Board Member
- Lord Mendoza, Independent Board Member
- Nicole Seligman, Independent Board Member
- Thomas E. Shenk, Ph.D., Independent Board Member
- Debra Yu, M.D., Independent Board Member
Last updated: 2024-12-31
Orgenesis Inc.
Point of Care (POCare) platform
Orgenesis Inc. is a biotech company focusing on cell and gene therapies. It offers a Point of Care (POCare) platform with a pipeline of POCare therapeutics produced in automated systems, targeting autologous therapies near the patient's point of care.
About | Contact | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | News | Careers | Directors | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ORGS
Recent Price: $2.11
Industry: Biotechnology
CEO: Ms. Vered Caplan M.Sc.
Sector: Healthcare
Employees: 146
Address: 20271 Goldenrod Lane, Germantown, MD 20876
Phone: 480 659 6404
Last updated: 2024-12-31